Related Experiment Video
Updated: Mar 2, 2026
07:30
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.5K
[Subclinical hypothyroidism in elderly people].
1V. F. Voyno-Yasenetskiy Krasnoyarsk State Medical University, Krasnoyarsk, 660022, Russian Federation; stk99@yandex.ru.
Advances in Gerontology = Uspekhi Gerontologii
|May 17, 2017
Summary
Subclinical hypothyroidism in the elderly presents unique clinical features. This review covers current diagnostic and treatment approaches for this common thyroid dysfunction in older adults.
Area of Science:
- Gerontology
- Endocrinology
- Thyroidology
Background:
- Subclinical hypothyroidism (SCH) is common in the elderly.
- It is defined by elevated thyroid-stimulating hormone (TSH) levels with normal free thyroxine (FT4) levels.
- SCH diagnosis and management in older adults require careful consideration due to potential benefits and risks of treatment.
Purpose of the Study:
- To review the clinical features of subclinical hypothyroidism in the elderly.
- To describe current diagnostic modalities for subclinical thyroid dysfunction in older individuals.
- To outline contemporary treatment strategies for subclinical hypothyroidism in the geriatric population.
Main Methods:
- Literature review of clinical studies and guidelines.
- Analysis of diagnostic criteria for subclinical hypothyroidism.
- Evaluation of treatment options and their evidence base in the elderly.
Main Results:
- Clinical presentation of SCH in the elderly can be subtle and overlap with age-related changes.
- Diagnosis relies on consistent TSH elevation and exclusion of other causes.
- Treatment decisions are individualized, balancing risks of overt hypothyroidism and potential benefits of thyroid hormone replacement.
Conclusions:
- Subclinical hypothyroidism in the elderly necessitates a nuanced approach to diagnosis and management.
- Individualized treatment strategies are crucial, considering patient-specific factors and potential outcomes.
- Further research is needed to optimize management protocols for SCH in older adults.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
288
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
303
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
303
01:20Synthesis and Regulation of Thyroid Hormones
8.4K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.4K